MAPT and Alzheimer disease: Additionally, circulating autoimmune antibodies have been studied as potential markers of underlying pathological mechanisms of neurodegenerative dementia; most studies have focused on antibodies specific for AD-associated proteins such as Aβ, tau protein and glial markers (11, 13).